The format of the dosimetry and therapy meeting has evolved from a series of interesting and important Radiopharmaceutical and dosimetry symposia held approximately every 5 years since 1970. This series was continued at the EANM congress 2004 (Helsinki) and at the SNM congress 2009 (Toronto). These symposia were formerly known by ISTARD: “International Symposium on Targeted Radiotherapy and Radiopharmaceutical Dosimetry”. From 2015 these symposia are organised annually parallel to the EANM congress and the name has changed to Do.MoRe, emphasizing both the importance of Dosimetry and the more regular organisation.
As a separate track within the EANM congress, this symposium will aim to bring together all disciplines concerned with Radiopharmaceutical Dosimetry, Physics, Radiobiology and Molecular Radiotherapy stimulating interdisciplinary scientific discussion.
As a prelude to Do.MoRe, a pre-symposium will be held on Monte Carlo based quantitative imaging reconstruction methods, focusing on PET and SPECT quantification for clinical use in Dosimetry and impact of image reconstruction techniques. Another pre-symposium will highlight the added value of Dosimetry guided Radionuclide Therapy, although at present it is seen as a great challenge to perform. Within the Do.MoRe a symposium is organised to outline the currently achievable accuracy in absorbed dose assessments and its reliability for predicting Radionuclide Therapy outcome.
The EANM Dosimetry, Therapy, Physics and Thyroid Committees will coordinate the scientific programme for the meeting jointly.
The Do.MoRe Track programme details listed hereunder will be updated constantly.